ABSTRACT:

Background: Epilepsy affects over 50 million individuals worldwide, making it one of the most prevalent neurological disorders. Anti-epileptic drugs (AEDs) serve as the primary treatment, enabling up to 70% of patients to achieve seizure freedom when adhering to an effective regimen. “Medication adherence” refers to the extent to which patients follow their prescribed medication schedules, including correct dosages and intervals. This concept emphasizes a patient-centered approach in healthcare, highlighting collaboration between patients and healthcare providers in developing treatment plans rather than a one-sided directive. Studies indicate that anti-epileptic drug (AED) non-adherence rates among adults with epilepsy range from 29% to 39%. This non-adherence undermines the effectiveness of AED regimens, leading to an increased risk of fractures, injuries, and automobile accidents. Additionally, retrospective research has shown that non-adherence contributes to higher healthcare utilization and
Costs as evidenced by increased emergency department visits and inpatient admissions.
Objective: To assess the prevalence of anti-epileptic medication adherence and associated factors among adult epileptic patients in Yekatite 12 Medical College, Addis Ababa, Ethiopia.
Method: A cross-sectional study involving adult epileptic patients at Yekatite 12 Medical College in Addis Ababa, Ethiopia, was carried out from May 3, 2024, to August 13, 2024. Data will be gathered using a structured questionnaire, and descriptive statistics will be used to analyze and present the results.
Result: Of 230 respondents, 130 (56.5%) were male, and 100 (43.5%) were female. Most of the patients, 160 (69.6%), were in the 20-45 age range, while only 11 (4.8%) were above 60. Most of the respondents, 155 (67.4%), identified as Orthodox, and nearly half, 109 (47.4%), were married. Additionally, 126 (54.8%) of the patients had access to primary education. Regarding employment, 104 (45.2%) were employed, and 9 (3.9%) were students. Lastly, 123 (53.5%) of the patients earned between 1000 and 5000.
Conclusion: The findings of this study show a low adherence rate to anti-epileptic drug (AED) treatment compared to the standard adherence rate of over 95%, which is necessary to effectively prevent seizure recurrence. Missing one or more doses of the AED regimen each week can lead to treatment failure and trigger seizures. In conclusion, 60% of the study participants adhered to their AED treatment, with forgetfulness being the main reason for non-adherence, followed by a busy lifestyle.

KEYWORDS :

Adherence, Anti-epileptic drugs, Armed Force Hospital.

REFERENCES :

1) World Health Organisation. Epilepsy fact sheet [internet]. 2016. Available from:
http://www.who.int/mediacentre/factsheets/fs999/en/. [cited 2016 February 26].
2) McAuley JW, McFadden LS, Elliott JO, Shneker BF. An evaluation of self-management behaviors and medication adherence. Epilepsy Behav 2008;13 (4):637–41.
3) Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat 2007;3(1):117–31.
4) Cramer J, Roy A, Burrell A, Fairchild CJ, Fuldeore MJ, Ollendorf DA. Medication compliance and persistence. Value Health 2008;11(1):44–7.
5) Kronish IM, Ye S. Adherence to cardiovascular medications: lessons learned and future directions. Prog Cardiovasc Dis 2013;55(6):560–600.
6) Davis KL, Candrilli SD, Edin ME. Prevalence and cost of non-adherence with anti-epileptic drugs in an adult managed care population. Epilepsia 2008;49 (3):446–54.
7) Faught RE, Duh MS, Weiner JR, Guerin A, Cunnington C. Non-adherence to anti-epileptic drugs and increased mortality: findings from the RANSOM study. Neurology 2008;71(20):1572–8.
8) Faught RE, Weiner JR, Geurin A, Cunnington C, Duh MS. Impact of non-adherence to anti-epileptic drugs on health care utilization and costs: findings from the RANSOM study. Epilepsia 2009;50(3):501–9.
9) Brodie M. The missing link: uncovering and managing poor adherence. 2014 June 29; Stockholm, Sweden: Highlights from the 11th European Congress on Epileptology 2014; p. 10.
10) Skinner HJ, Durbon-Murcia SA, Thompson AR, Medina MT, Edwards JC, Nicholas JS, et al. Adult convulsive status epilepticus in the developing country of Honduras. Seizure 2010;19(6):363–7.
11) Lathers CM, Koehlar SA, Wecht CH, Schraeder PL. Forensic anti-epileptic drug levels in autopsy cases of epilepsy. Epilepsy Behav 2011;22(4):778–85.
12) Tang F, Zhu G, Jiao Z, Ma C, Wang B. Self-reported adherence in patients with epilepsy who missed their medications and reasons for non-adherence in China. Epilepsy Behav 2013;27(1):85–9.
13) Harimanana A, Clavel S, Chivorakul P, Perez F, Preux PM, Barennes H. Associated factors with adherence to the anti-epileptic drug in the capital city of Lao PDR. Epilepsy Res 2013;104(1–2):158–66.
14) Zeber JE, Copeland LA, Pugh MJV. Variation in anti-epileptic drug adherence among older patients with new-onset epilepsy. Ann Pharmacother 2010; 44:1896–904.
15) Sweileh WM, Ihbesheh MS, Jarar IS, Taha ASA, Sawalha AF, Zyoud SH, et al. Self-reported medication adherence and treatment satisfaction in patients with epilepsy. Epilepsy Behav 2011;21(3):301–5.
16) Buck D, Jacoby A, Baker GA, Chadwick DW. Factors influencing compliance with anti-epileptic drug regimes. Seizure 1997;6(2):87–93.
17) Paschal AM, Rush SE, Sadler T. Factors associated with medication adherence in patients with epilepsy and recommendations for improvement. Epilepsy Behav 2014;31(1):346–50.
18) Smithson WH, Hukins D, Colwell B, Mathers N. Developing a method to identify medicines non-adherence in a community sample of adults with epilepsy. Epilepsy Behav 2012; 24:49–5
19) Eraker SA, Kirscht JP, Becker MH, et al. Understanding and improving patient compliance. Ann Intern Med. 1984, 10(2):258-68.
20) LeppikIE.How to get patients with epilepsy to take their medication. The problem of noncompliance. Postgrad Med. 1990, 88(1):253-6.
21) GomesMda M, Maia FilhoHde S. Medication-taking behavior and drug self-regulation in people with epilepsy. Arq Neuropsiquitar.1998, 56:714-9.
22) Wolters Kluwer-medknow, journal of family medicine and primary care 2312-2317, July 2019.
23) Eatock J, Baker GA. Managing patient adherence and quality of life in epilepsy. Neuropsychiatr Dis Treat. 2007, 3(1):117-31
24) Greenhouse WJ, Meyer B, Johnson SL. Coping and medication adherence in bipolar disorder. J Affect Disord.2004, 59:237-41.
25) Kleindienst N, Greil W. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder? J Clin Psychiatry.2004, 65:966-74.